Tag:
Allozyne
Latest Headlines
Latest Headlines
After calling off Poniard merger, Allozyne "redistributing" staff
Just before the Christmas break, Allozyne called off its attempt to go public by merging with Poniard , a public company in San Francisco that has seen its share price eviscerated over the course of
Biotech Allozyne aims for 'backdoor' public debut
Intrepid biotechs tend to get creative about financing strategies when traditional funding routes appear too rocky to traverse. After considering a traditional IPO, little-known biotech Allozyne is
Allozyne goes public via merger with Poniard
San Francisco's Poniard Pharmaceuticals and Seattle-based Allozyne are both getting what they want out of a merger deal announced yesterday. Allozyne, which is developing protein therapeutics for
